Kathmere Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Kathmere Capital Management, LLC

  • $1.06 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021
SELL
$446.73 - $548.2 $127,764 - $156,785
-286 Closed
0 $0
Q3 2020

Nov 20, 2020
BUY
$544.75 - $658.21 $155,798 - $188,248
286 New
286 $160,000
Q1 2020

May 06, 2020
SELL
$336.18 - $494.43 $219,189 - $322,368
-652 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $178,732 - $245,484
652 New
652 $245,000

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email